Puff, puff, cure colorectal cancer, pass….This might one day be the chant of doctors everywhere, depending on the accuracy of a recent study at M.D. Anderson.
Researchers there have announced that a “cannabinoid receptor” in cells might be a key tumor-fighting tool in patients with colorectal cancer.
In a press release, MD Anderson’s executive vice president Raymond Dubois stated: “Potential application of cannabinoids as anti-tumor drugs is an exciting prospect, because cannabinoid agonists are being evaluated now to treat the side effects of chemotherapy and radiation therapy.”
Roughly translated, this means that preclinical tests show that sparking a bowl seems to spark the tumor-fighting capabilities of a certain cellular receptor – and it’s a lot more fun than chemo.
For those not in the know, the press release states that “external cannabinoids include manmade versions and those present in plants, most famously the active ingredient in marijuana (THC).” (We like that term, “most famously”).
Although it’s not mentioned in the press release, this latest breakthrough appears to advance decades’ worth of research from such giants in the field as Drs. Spicoli, Dogg, Cheech, Slater, and Chong.
-- Craig Malisow
Keep the Houston Press Free... Since we started the Houston Press, it has been defined as the free, independent voice of Houston, and we would like to keep it that way. Offering our readers free access to incisive coverage of local news, food and culture. Producing stories on everything from political scandals to the hottest new bands, with gutsy reporting, stylish writing, and staffers who've won everything from the Society of Professional Journalists' Sigma Delta Chi feature-writing award to the Casey Medal for Meritorious Journalism. But with local journalism's existence under siege and advertising revenue setbacks having a larger impact, it is important now more than ever for us to rally support behind funding our local journalism. You can help by participating in our "I Support" membership program, allowing us to keep covering Houston with no paywalls.